cyclohexanol has been researched along with Pain in 91 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 20 (21.98) | 18.7374 |
1990's | 8 (8.79) | 18.2507 |
2000's | 38 (41.76) | 29.6817 |
2010's | 24 (26.37) | 24.3611 |
2020's | 1 (1.10) | 2.80 |
Authors | Studies |
---|---|
Budde, H; Coronado-Álvarez, A; Imperatori, C; Machado, S; Macías-Triana, L; Murillo-Rodríguez, E; Romero-Cordero, K; Tatum-Kuri, A; Vera-Barrón, A; Yamamoto, T | 1 |
Anan, K; Hara, S; Hasebe, N; Kai, H; Kume, M; Masui, M; Ohara, M; Shimada, S; Shinohara, S; Tsuji, H; Yagi, S; Yamamoto, S | 1 |
France, CP; Minervini, V | 1 |
Henderson-Redmond, AN; LaFleur, RA; Morgan, DJ; Wilson, RP | 1 |
Huang, X; Ji, JL; Li, C; Luo, YL; Wang, B | 1 |
Fujita, F; Takaishi, M; Tominaga, M; Uchida, K | 1 |
Scheinfeld, N | 1 |
Kinder, B; Litner, J; Panganiban, B | 1 |
Chen, CY; Hung, CI; Liu, CY; Wang, SJ; Yang, CH | 1 |
Barber, JK; Bombardier, CH; Brooks, L; Chiodo, AE; Fann, JR; Heinemann, AW; McCullumsmith, C; Richards, JS; Tate, DG; Temkin, NR; Wilson, CS | 1 |
Buck, B; Grönniger, E; Holtzmann, U; Jung, KA; Neufang, G; Rippke, F; Schoelermann, AM; Stäb, F; Sulzberger, M; Wenck, H; Worthmann, AC | 1 |
Buck, B; Conzelmann, S; Grönniger, E; Jung, KA; Schoelermann, AM | 1 |
Gupta, K; Gupta, M; Jahagirdar, B; Lamarre, Y; Mittal, A | 1 |
Sidaway, P | 1 |
Belardi, JK; Bray, JA; Burroughs, KD; Cohn, ST; Cosmi, SA; Deecher, DC; Gavrin, LK; Ho, DM; Johnston, GH; Koury, EJ; Leiter, J; Leventhal, L; Mahaney, PE; Mugford, CA; Platt, B; Rosenzweig-Lipson, SJ; Sabatucci, JP; Santilli, AA; Smith, VA; Stack, GP; Trybulski, EJ; Vu, TA; Ye, F; Zhang, Y | 1 |
Barrot, M; Doridot, S; Freund-Mercier, MJ; Hein, L; Petit-Demoulière, N; Tessier, LH; Yalcin, I | 1 |
Begré, S; Gerber, M; Traber, M; von Känel, R | 3 |
Kane, SA; Liang, A; Sain, NM; Urban, MO | 1 |
Booker, L; Lichtman, AH; Mahadevan, A; Naidu, PS; Razdan, RK | 1 |
Dykstra, LA; Fischer, BD; Henry, FE; Ward, SJ | 1 |
Bolognini, D; Cascio, MG; Corelli, F; Di Marzo, V; Maione, S; Palazzo, E; Pasquini, S; Pertwee, RG | 1 |
Jamshidzadeh, A; Kianrad, R; Mohammadi-Samani, S; Montaseri, H; Rangbar-Zahedani, M | 1 |
Ericson, ME; Gupta, K; Gupta, P; Gupta, V; Hebbel, RP; Kehl, LJ; Khasabov, SG; Kohli, DR; Li, Y; Nguyen, J; Simone, DA | 1 |
Bitter, I; Karamustafalioglu, O; Koponen, H; Mohr, P; Sartorius, N; Seifritz, E; Svestka, J | 1 |
Liu, X; Mullins, CD; Wang, J | 1 |
Cain, DM; Gupta, K; Hebbel, RP; Simone, DA; Vang, D | 1 |
Dykstra, LA; Miller, LL; Picker, MJ; Schmidt, KT; Umberger, MD | 1 |
Kwilasz, AJ; Negus, SS | 1 |
Dogrul, A; Gardell, LR; Lai, J; Ma, S; Ossipov, MH; Porreca, F | 1 |
Dikici, S; Kadiroglu, AK; Kara, IH; Yilmaz, ME | 1 |
Briley, M | 2 |
Stewart, DE | 1 |
Alloui, A; Ardid, D; Chapuy, E; Eschalier, A; Hernandez, A; Jourdan, D; Marchand, F; Pelissier, T | 1 |
Ak, I; Aksu, G; Sayar, K; Tosun, M | 1 |
Houlihan, DJ | 1 |
Burton, D; Camilleri, M; Chial, HJ; Delgado-Aros, S; Ferber, I; McKinzie, S; Zinsmeister, AR | 1 |
Angus, JA; Scott, DA; Wright, CE | 1 |
Bo-Hua, Z; He, L; Hong-Ju, Y; Jun-Wei, W; Nan, Z; Wei-Guo, S; Wei-Xiu, Y; Zhe-Hui, G; Zheng-Hua, G; Zhi-Pu, L; Zhong-Wei, J | 1 |
Albano, D; Grothe, DR; Scheckner, B | 1 |
Hemrick-Luecke, SK; Iyengar, S; Simmons, RM; Webster, AA; Xu, JY | 1 |
Delgado, PL | 1 |
Altun Ugur, B; Arikan, E; Guldiken, B; Guldiken, S; Kara, M; Tugrul, A | 1 |
Angus, JA; Tham, SM; Tudor, EM; Wright, CE | 1 |
Boulet, JM; Chaffer, SM; Elsemore, DA; Gottshall, SL; Harrison, JE; Koetzner, L; Lee, G; Mark, L; Miller, W; Pearson, MS; Rabadi, L; Rotshteyn, Y; Shan, S; Tafesse, L; Toth, M; Turchin, PI; Valenzano, KJ; Whiteside, GT | 1 |
Khodayar, MJ; Naderi, N; Shafaghi, B; Zarindast, MR | 1 |
Brain, C; Chen, A; Courade, JP; Dyson, A; Fox, A; Groarke, A; Loong, Y; Peacock, M; Yaqoob, M | 1 |
Antoniou, K; Daifoti, Z; Galanopoulos, A; Kourouli, T; Marselos, M; Nahmias, V; Panagis, G; Papahatjis, D; Spyraki, C; Thermos, K; Vlachou, S | 1 |
Aricioğlu, F; Buldanlioğlu, U; Ozyalçin, NS; Salanturoğlu, G | 1 |
Bjerrum, OJ; Blackburn-Munro, G; Broløs, T; Rode, F | 1 |
Choong, KC; Su, X; Urban, MO | 1 |
Robinson-Papp, J; Simpson, DM | 1 |
Anifandis, G; Anifantis, G; Chinou, I; Galanopoulou, P; Kourounakis, AP; Liapi, C; Theodosopoulos, S | 1 |
Chandran, P; Dart, MJ; Daza, AV; Fan, Y; Frost, JM; Garrison, TR; Grayson, GK; Honore, P; Hsieh, GC; Meyer, MD; Pai, M; Salyers, AK; Sullivan, JP; Wensink, EJ; Yao, BB; Zhu, CZ | 1 |
Melvin, LS; Milne, GM; Weissman, A | 1 |
Lenzhofer, R; Moser, K | 1 |
Madler, C; Morawetz, RF; Parth, P | 1 |
Dworzak, H; Lehmann, KA; Rehme, U | 1 |
Harbert, CA; Johnson, MR; Melvin, LS; Milne, GM; Weissman, A | 1 |
Brodanová, M; Pesková, M | 1 |
Giertz, H; Richter, W; von Arnim, B | 1 |
Staquet, MJ | 1 |
Kropp, J; Rettig, G | 1 |
Schulte, H; Songer, DA | 1 |
Rowbotham, MC; Taylor, K | 1 |
Balster, RL; Compton, DR; Dutta, A; Gordon, PM; Lichtman, AH; Martin, BR; Razdan, RK; Siegel, C; Singer, M; Wiley, JL | 1 |
Bhatia, SC; Gupta, S; Theesen, KA | 1 |
Markowitz, JS; Patrick, KS | 1 |
Lowe, J; Mason, DJ; Welch, SP | 1 |
Davis, JL; Smith, RL | 1 |
Eads, M; Embrey, JP; Houser, SJ; Welch, SP | 1 |
Kiayias, JA; Lakka-Papadodima, E; Vlachou, ED | 1 |
Bencomo, L; Bhatia, SC; Bhatia, SK | 1 |
Michael, A | 1 |
Lithner, F | 1 |
Hohmann, AG; Tsou, K; Walker, JM | 1 |
Arendt-Nielsen, L; Enggaard, TP; Gram, LF; Klitgaard, NA; Sindrup, SH | 1 |
Moulin, DE; Sumpton, JE | 1 |
Arend, I; Schenck, EG | 2 |
Arend, I; Flohé, L; Nijssen, J; Scheele, J; von Arnim, B | 1 |
Arend, I; Cogal, A; Flohé, L; Richter, W; Simon, W | 1 |
Rost, A; Schenck, EG | 1 |
Banerjee, AK; Dhasmana, KM; Erdmann, W; Rating, W | 1 |
Bromm, B; Herrmann, WM; Scharein, E | 1 |
Granitzki, HW; Neddermann, E; Rohdewald, P | 1 |
Chaturachinda, K; Padmasuta, K; Pausawasdi, S; Tangtrakul, S | 1 |
Abatzi, TA; Gaupmann, G; Mittelbach, G; Schneider, S; Stacher, G; Stacher-Janotta, G; Steinringer, H | 1 |
Barth, H; Flohé, L; Giertz, H; Richter, W | 1 |
9 review(s) available for cyclohexanol and Pain
Article | Year |
---|---|
The synthetic CB
Topics: Analgesics; Animals; Anti-Anxiety Agents; Cannabinoid Receptor Agonists; Cannabinoids; Controlled Substances; Cyclohexanols; Dronabinol; Humans; Mental Disorders; Pain; Phenanthridines; Receptor, Cannabinoid, CB1 | 2021 |
Treatment of hidradenitis supprurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine.
Topics: Acetaminophen; Amines; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Hidradenitis Suppurativa; Humans; Pain; Pain Management; Pregabalin; Pyrazoles; Selective Serotonin Reuptake Inhibitors; Sulfonamides; Thiophenes; Venlafaxine Hydrochloride | 2013 |
A painful urologic emergency.
Topics: Cyclohexanols; Emergencies; Emergency Service, Hospital; Follow-Up Studies; Humans; Male; Middle Aged; Pain; Priapism; Risk Assessment; Treatment Outcome; Urologic Diseases; Urologic Surgical Procedures, Male; Venlafaxine Hydrochloride | 2014 |
New hope in the treatment of painful symptoms in depression.
Topics: Animals; Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Cyclopropanes; Depressive Disorder; Duloxetine Hydrochloride; Humans; Milnacipran; Pain; Thiophenes; Venlafaxine Hydrochloride | 2003 |
Physical symptoms of depression: unmet needs in special populations.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Child; Comorbidity; Cyclohexanols; Delivery of Health Care; Depressive Disorder; Diagnosis, Differential; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Pain; Poverty; Selective Serotonin Reuptake Inhibitors; Sex Factors; Thiophenes; Venlafaxine Hydrochloride | 2003 |
Treatment of pain syndromes with venlafaxine.
Topics: Analgesics; Animals; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Humans; Pain; Pain, Postoperative; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2004 |
Common pathways of depression and pain.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Brain; Chronic Disease; Cyclohexanols; Depressive Disorder; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neurodegenerative Diseases; Neuronal Plasticity; Neurons; Norepinephrine; Pain; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Clinical experience with dual action antidepressants in different chronic pain syndromes.
Topics: Antidepressive Agents; Chronic Disease; Cyclohexanols; Cyclopropanes; Duloxetine Hydrochloride; Humans; Milnacipran; Pain; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Safety profile of treatment in diabetic peripheral neuropathic pain.
Topics: Administration, Topical; Analgesics; Anesthetics, Local; Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Capsaicin; Cyclohexanols; Diabetic Neuropathies; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Pain; Pregabalin; Thiophenes; Venlafaxine Hydrochloride | 2007 |
19 trial(s) available for cyclohexanol and Pain
Article | Year |
---|---|
Efficacy of venlafaxine XR for the treatment of pain in patients with spinal cord injury and major depression: a randomized, controlled trial.
Topics: Adolescent; Adult; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Medication Adherence; Middle Aged; Neuralgia; Nociceptive Pain; Pain; Psychiatric Status Rating Scales; Spinal Cord Injuries; Trauma Severity Indices; Venlafaxine Hydrochloride; Young Adult | 2015 |
Effective treatment for sensitive skin: 4-t-butylcyclohexanol and licochalcone A.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcitonin Gene-Related Peptide; Capsaicin; Cell Line; Chalcones; Cyclohexanols; Dinoprostone; Dipeptides; Dose-Response Relationship, Drug; Drug Combinations; Erythema; Facial Dermatoses; Female; Humans; Male; Middle Aged; Neurons; NF-kappa B; Pain; Sensation Disorders; Signal Transduction; Single-Blind Method; Skin Cream; Swine; TRPV Cation Channels; Young Adult | 2016 |
Comparison of skin calming effects of cosmetic products containing 4-t-butylcyclohexanol or acetyl dipeptide-1 cetyl ester on capsaicin-induced facial stinging in volunteers with sensitive skin.
Topics: Adult; Aged; Capsaicin; Cosmetics; Cyclohexanols; Dipeptides; Facial Dermatoses; Female; Humans; Middle Aged; Pain; Sensation Disorders; Severity of Illness Index; Single-Blind Method; Time Factors; Young Adult | 2016 |
Venlafaxine treatment of fibromyalgia.
Topics: Adrenergic Uptake Inhibitors; Adult; Anxiety; Cyclohexanols; Depression; Female; Fibromyalgia; Humans; Pain; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Buspirone; Colon; Compliance; Cyclohexanols; Double-Blind Method; Fasting; Female; Humans; Male; Pain; Postprandial Period; Pressure; Reference Values; Selective Serotonin Reuptake Inhibitors; Sensory Thresholds; Serotonin Receptor Agonists; Venlafaxine Hydrochloride | 2003 |
[Analgesic effect of tramadol in patients with malignant diseases].
Topics: Adult; Clinical Trials as Topic; Cyclohexanols; Drug Tolerance; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Pain; Tramadol | 1984 |
Analgesic effect of ciramadol in patients with chronic pain.
Topics: Adult; Aged; Amines; Analgesics; Benzylamines; Chemical Phenomena; Chemistry; Chronic Disease; Clinical Trials as Topic; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Pain; Placebos; Time Factors | 1980 |
Venlafaxine hydrochloride and chronic pain.
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Cyclohexanols; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1996 |
Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans.
Topics: Adult; Analgesics; Antidepressive Agents, Second-Generation; Cold Temperature; Cross-Over Studies; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Electric Stimulation; Female; Humans; Male; Pain; Pain Measurement; Pain Threshold; Pressure; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2001 |
[Clinical trial of tramadol by means of the "paired card" system (author's transl)].
Topics: Analgesics; Clinical Trials as Topic; Cyclohexanols; Dipyrone; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Pain; Placebos; Statistics as Topic | 1978 |
[Tramadol and pentazocine in a clinical double-blind crossover comparison].
Topics: Adult; Aged; Analgesics; Clinical Trials as Topic; Cyclohexanols; Double-Blind Method; Female; Hemodynamics; Humans; Male; Middle Aged; Pain; Pentazocine; Psychoses, Substance-Induced; Respiration | 1978 |
[The effect of tramadol in an open clinical trial (author's transl)].
Topics: Adult; Aged; Analgesics; Clinical Trials as Topic; Cyclohexanols; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Pain; Suppositories; Time Factors | 1978 |
[Clinical study on the development of dependency after long-term treatment with tramadol (author's transl)].
Topics: Analgesics; Clinical Trials as Topic; Cyclohexanols; Humans; Naloxone; Pain; Placebos; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1978 |
[The effect of tramadol and other analgesics on the pain threshold in human dental pulp (author's transl)].
Topics: Adult; Analgesics; Cyclohexanols; Dental Pulp; Female; Humans; Male; Pain; Time Factors | 1978 |
[Comparison of the action of 2 effective analgesics. Experimental study: tramadol versus tilidine/naloxone].
Topics: Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Cyclohexanols; Double-Blind Method; Drug Combinations; Humans; Naloxone; Pain; Pain Measurement; Random Allocation; Tilidine; Tramadol | 1989 |
Comparison of the analgesic efficacy of metamizole and tramadol in experimental pain.
Topics: Administration, Oral; Adult; Aminopyrine; Clinical Trials as Topic; Cyclohexanols; Dipyrone; Double-Blind Method; Female; Humans; Male; Pain; Random Allocation; Sleep Stages; Time Factors; Tramadol; Xerostomia | 1988 |
The efficacy of tramadol in the interval laparoscopic sterilization: a comparison of two dosage regimen.
Topics: Adult; Cyclohexanols; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Pain; Random Allocation; Sterilization, Tubal; Tramadol | 1988 |
Effects of graded oral doses of a new 5-hydroxytryptamine/noradrenaline uptake inhibitor (Ro 15-8081) in comparison with 60 mg codeine and placebo on experimentally induced pain and side effect profile in healthy men.
Topics: Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Codeine; Cyclohexanols; Electric Stimulation; Emotions; Hot Temperature; Humans; Male; Norepinephrine; Pain; Psychomotor Performance; Reaction Time; Serotonin Antagonists | 1987 |
Clinical investigation on the development of dependence during oral therapy with tramadol.
Topics: Administration, Oral; Adult; Aged; Cyclohexanols; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Naloxone; Pain; Precipitin Tests; Random Allocation; Substance Withdrawal Syndrome; Substance-Related Disorders; Tramadol | 1985 |
63 other study(ies) available for cyclohexanol and Pain
Article | Year |
---|---|
Discovery of orally bioavailable cyclohexanol-based NR2B-selective NMDA receptor antagonists with analgesic activity utilizing a scaffold hopping approach.
Topics: Administration, Oral; Analgesics; Animals; Brain; Cyclohexanols; Dose-Response Relationship, Drug; Drug Discovery; Formaldehyde; HEK293 Cells; Humans; Mice; Molecular Structure; Pain; Rats; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2017 |
Effects of morphine/CP55940 mixtures on an impulsive choice task in rhesus monkeys.
Topics: Analgesics, Opioid; Animals; Cannabinoid Receptor Agonists; Choice Behavior; Cyclohexanols; Dose-Response Relationship, Drug; Impulsive Behavior; Macaca mulatta; Male; Morphine; Pain; Receptor, Cannabinoid, CB1; Receptors, Opioid, mu; Reinforcement, Psychology | 2018 |
Sex differences in antinociceptive response to Δ-9-tetrahydrocannabinol and CP 55,940 in the mouse formalin test.
Topics: Analgesics; Analysis of Variance; Animals; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Female; Formaldehyde; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Pain; Pain Measurement; Receptor, Cannabinoid, CB1; Sex Characteristics; Time Factors; Treatment Outcome | 2018 |
Efficacy of venlafaxine extended-release monotherapy for first-episode depression with painful physical symptoms.
Topics: Adult; Antidepressive Agents, Second-Generation; Cohort Studies; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Prospective Studies; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Inhibitory effects of monoterpenes on human TRPA1 and the structural basis of their activity.
Topics: Analgesics; Calcium Channels; Camphanes; Camphor; Cells, Cultured; Cyclohexanols; Dose-Response Relationship, Drug; Eucalyptol; HEK293 Cells; Humans; Hydroxides; Monoterpenes; Nerve Tissue Proteins; Norbornanes; Pain; Transient Receptor Potential Channels; TRPA1 Cation Channel | 2014 |
The impacts of migraine and anxiety disorders on painful physical symptoms among patients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Analgesics; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder, Major; Disease Management; Female; Humans; Male; Middle Aged; Migraine Disorders; Pain; Pain Measurement; Symptom Assessment; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2014 |
Quantification of pain in sickle mice using facial expressions and body measurements.
Topics: Analgesics; Anemia, Sickle Cell; Animals; Behavior, Animal; Cold Temperature; Cyclohexanols; Disease Models, Animal; Facial Expression; Female; Humans; Male; Mice; Mice, Transgenic; Pain; Pain Measurement; Posture; Reproducibility of Results; Research Design | 2016 |
Pain: SHIP-1 activation for IC/BPS?
Topics: Cyclohexanols; Cystitis, Interstitial; Humans; Indans; Pain; Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 2016 |
Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.
Topics: Animals; Cell Line; Cyclohexanols; Ethylamines; Female; Humans; Male; Mice; Models, Molecular; Molecular Structure; Norepinephrine; Pain; Rats; Structure-Activity Relationship; Symporters | 2008 |
Beta2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amines; Animals; Anticonvulsants; Antidepressive Agents; Cyclohexanecarboxylic Acids; Cyclohexanols; Desipramine; Gabapentin; gamma-Aminobutyric Acid; Male; Mice; Mice, Transgenic; Morpholines; Pain; Pain Threshold; Propanolamines; Reboxetine; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-2; Sciatic Nerve; Venlafaxine Hydrochloride; Yohimbine | 2009 |
Regional origin and decrease of pain in patients with depressive symptoms under treatment with venlafaxine.
Topics: Acculturation; Adult; Analgesics; Antidepressive Agents, Second-Generation; Chronic Disease; Comorbidity; Culture; Cyclohexanols; Depression; Ethnicity; Europe; Europe, Eastern; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Physicians, Family; Psychophysiologic Disorders; Severity of Illness Index; Switzerland; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.
Topics: Analgesics; Animals; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Freund's Adjuvant; Hot Temperature; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Pain; Pain Measurement; Physical Stimulation; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Spinal Nerves | 2009 |
Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
Topics: Acetic Acid; Analgesics; Animals; Anti-Obesity Agents; Camphanes; Cannabinoids; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Male; Mice; Mice, Inbred ICR; Motor Activity; Pain; Pain Measurement; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; RNA, Messenger | 2009 |
Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects.
Topics: Analgesics; Analgesics, Opioid; Animals; Cyclohexanols; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Excitatory Amino Acid Antagonists; Hot Temperature; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Morphine; Pain; Pain Measurement; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate | 2010 |
In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB(2) receptor inverse agonists.
Topics: Analgesics; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclohexanols; Drug Inverse Agonism; Formaldehyde; Guanosine 5'-O-(3-Thiotriphosphate); Mice; Molecular Structure; Pain; Quinolones; Radioligand Assay; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2010 |
The effects of some permeability enhancers on the percutaneous absorption of lidocaine.
Topics: Administration, Cutaneous; Anesthetics, Local; Animals; Cyclohexane Monoterpenes; Cyclohexanols; Cyclohexenes; Dimethyl Sulfoxide; Drug Interactions; Lidocaine; Monoterpenes; Pain; Permeability; Polysorbates; Rats; Skin; Skin Absorption | 2010 |
Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.
Topics: Anemia, Sickle Cell; Animals; Behavior, Animal; Calcitonin Gene-Related Peptide; Cannabinoid Receptor Agonists; Cannabinoids; Cyclohexanols; Disease Models, Animal; Female; Hemoglobin, Sickle; Humans; Hyperalgesia; Male; Mice; Mice, Knockout; Mice, Transgenic; Morphine; Neuroglia; Pain; Receptors, Opioid, mu; Recombinant Proteins; Skin; Spinal Cord; Substance P | 2010 |
Management of depression in the presence of pain symptoms.
Topics: Antidepressive Agents; Brain; Chronic Disease; Clinical Trials as Topic; Combined Modality Therapy; Comorbidity; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Therapy, Combination; Duloxetine Hydrochloride; Fibromyalgia; Humans; Milnacipran; Mind-Body Relations, Metaphysical; Norepinephrine; Pain; Psychotherapy; Serotonin; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Physician speciality and pain reduction in patients with depressive symptoms under treatment with venlafaxine.
Topics: Adult; Aged; Analgesics; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Depressive Disorder; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Perception; Physicians; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.
Topics: Adolescent; Adult; Algorithms; Antidepressive Agents; Chronic Disease; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dosage Forms; Duloxetine Hydrochloride; Female; Humans; Male; Medication Adherence; Middle Aged; Pain; Retrospective Studies; Somatoform Disorders; Thiophenes; Venlafaxine Hydrochloride; Young Adult | 2011 |
Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness.
Topics: Age Factors; Analgesics; Anemia, Sickle Cell; Animals; Cannabinoid Receptor Antagonists; Cyclohexanols; Disease Models, Animal; Humans; Hyperalgesia; Hypoxia; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pain; Pain Measurement; Temperature | 2012 |
Effects of alterations in cannabinoid signaling, alone and in combination with morphine, on pain-elicited and pain-suppressed behavior in mice.
Topics: Amidohydrolases; Analgesics; Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Modulators; Carbamates; Cyclohexanols; Endocannabinoids; Male; Mice; Mice, Inbred C57BL; Morphine; Nociception; Pain; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1 | 2012 |
Dissociable effects of the cannabinoid receptor agonists Δ9-tetrahydrocannabinol and CP55940 on pain-stimulated versus pain-depressed behavior in rats.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Brain; Cannabinoid Receptor Agonists; Conditioning, Operant; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Eating; Electrodes, Implanted; Ketoprofen; Lactic Acid; Male; Pain; Rats; Rats, Sprague-Dawley; Self Stimulation | 2012 |
'Knock-down' of spinal CB1 receptors produces abnormal pain and elevates spinal dynorphin content in mice.
Topics: Analgesics; Animals; Antibodies; Benzoxazines; Cyclohexanols; Dizocilpine Maleate; Dynorphins; Excitatory Amino Acid Antagonists; Male; Mice; Mice, Inbred ICR; Morpholines; Naphthalenes; Oligodeoxyribonucleotides, Antisense; Pain; Receptors, Cannabinoid; Receptors, Drug; Spinal Cord; Tritium | 2002 |
Venlafaxine in the treatment of painful peripheral diabetic neuropathy in a uremic patient undergoing hemodialysis.
Topics: Adult; Analgesics; Cyclohexanols; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Humans; Pain; Uremia; Venlafaxine Hydrochloride | 2002 |
Evidence for a monoamine mediated, opioid-independent, antihyperalgesic effect of venlafaxine, a non-tricyclic antidepressant, in a neurogenic pain model in rats.
Topics: alpha-Methyltyrosine; Analgesics; Animals; Antidepressive Agents; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Fenclonine; Male; Mononeuropathies; Motor Activity; Naloxone; Narcotic Antagonists; Pain; Pain Threshold; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Venlafaxine Hydrochloride; Vocalization, Animal | 2003 |
Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine.
Topics: Analgesics, Opioid; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Pain; Polypharmacy; Serotonin Syndrome; Tramadol; Venlafaxine Hydrochloride | 2004 |
Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat.
Topics: Analgesics; Analysis of Variance; Animals; Behavior, Animal; Camphanes; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Ligation; Male; Nociceptors; Pain; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Spinal Nerves; Time Factors | 2004 |
Effect of gabapentin derivates on mechanical allodynia-like behaviour in a rat model of chronic sciatic constriction injury.
Topics: Amines; Animals; Chronic Disease; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Memantine; Pain; Pain Threshold; Pregabalin; Prodrugs; Rats; Sciatic Neuropathy; Structure-Activity Relationship; Venlafaxine Hydrochloride | 2004 |
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Complete relief of pain in acute painful diabetic neuropathy of rapid glycaemic control (insulin neuritis) with venlafaxine HCL.
Topics: Acute Disease; Analgesics; Blood Glucose; Cyclohexanols; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Male; Middle Aged; Pain; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
Topics: Acute Disease; Adrenergic alpha-Agonists; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Cannabinoids; Cyclohexanols; Dexmedetomidine; Dose-Response Relationship, Drug; Drug Synergism; Injections, Spinal; Male; Mice; Morphine; Pain; Pain Measurement; Receptors, Opioid, mu | 2005 |
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy.
Topics: Amines; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anxiety; Ataxia; Behavior, Animal; Benzoxazines; Binding, Competitive; Catalepsy; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Cyclohexanecarboxylic Acids; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Immunosuppressive Agents; Indoles; Indomethacin; Inflammation; Male; Mice; Mice, Knockout; Morpholines; Naphthalenes; Pain; Pain Measurement; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Cannabinoid, CB2; Time Factors | 2005 |
Interaction between gamma-aminobutyric acid GABAB and cannabinoid CB1 receptors in spinal pain pathways in rat.
Topics: Analysis of Variance; Animals; Baclofen; Cyclohexanols; Dose-Response Relationship, Drug; Drug Interactions; Formaldehyde; GABA Agonists; GABA Antagonists; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; Injections, Spinal; Male; Pain; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, GABA-B; Rimonabant; Signal Transduction; Spinal Cord | 2005 |
Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat.
Topics: Analgesics; Animals; Benzoxazines; Cannabinoids; Catalepsy; Cell Line; Chromatography; Cricetinae; Cricetulus; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Freund's Adjuvant; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hypothermia; Inflammation; Ligation; Male; Morpholines; Motor Activity; Naphthalenes; Pain; Pain Measurement; Pain Threshold; Radioligand Assay; Rats; Rats, Wistar; Rotarod Performance Test; Sciatic Neuropathy; Sulfur Isotopes; Time Factors; Tritium | 2005 |
Behavioral pharmacological properties of a novel cannabinoid 1',1'-dithiolane delta8-THC analog, AMG-3.
Topics: Animals; Behavior, Animal; Binding, Competitive; Cannabinoids; Catalepsy; Cell Membrane; Cerebral Cortex; Cyclohexanols; Dose-Response Relationship, Drug; Male; Molecular Structure; Motor Activity; Pain; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Time Factors; Tritium | 2005 |
Evaluation of antinociceptive and anti-inflammatory effects of venlafaxine in the rat.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Carrageenan; Cyclohexanols; Disease Models, Animal; Edema; Female; Male; Mice; Mice, Inbred BALB C; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride | 2005 |
Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain.
Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Cyclohexanols; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Kidney; Male; Neuralgia; Pain; Pain Measurement; Rats; Rats, Inbred BN; Venlafaxine Hydrochloride | 2006 |
Effect of CP55,940 on mechanosensory spinal neurons following chronic inflammation.
Topics: Afferent Pathways; Animals; Cannabinoid Receptor Modulators; Cannabinoids; Chronic Disease; Cyclohexanes; Cyclohexanols; Dose-Response Relationship, Drug; Inflammation; Male; Mechanoreceptors; Nociceptors; Pain; Phenols; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid | 2007 |
Antinociceptive properties of 1,8-Cineole and beta-pinene, from the essential oil of Eucalyptus camaldulensis leaves, in rodents.
Topics: Analgesics; Animals; Bicyclic Monoterpenes; Bridged Bicyclo Compounds; Cyclohexanols; Eucalyptol; Eucalyptus; Male; Mice; Monoterpenes; Oils, Volatile; Pain; Phytotherapy; Plant Leaves; Rats; Rats, Wistar; Structure-Activity Relationship | 2007 |
In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models.
Topics: Analgesics, Non-Narcotic; Animals; Arthritis, Experimental; Cells, Cultured; Constriction, Pathologic; Cyclic AMP-Dependent Protein Kinases; Cyclohexanols; Cyclopropanes; Humans; Hyperalgesia; Immunosuppressive Agents; Joints; Male; Microscopy, Fluorescence; Morpholines; Motor Activity; Pain; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Sciatica | 2008 |
Change in pain severity with open label venlafaxine use in patients with a depressive symptomatology: an observational study in primary care.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Chronic Disease; Comorbidity; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Threshold; Primary Health Care; Somatoform Disorders; Switzerland; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol.
Topics: Amphetamine; Analgesia; Animals; Anticonvulsants; Apomorphine; Behavior, Animal; Body Temperature; Cyclohexanols; Dogs; Dronabinol; Drug Interactions; Male; Mice; Motor Activity; Pain; Tetrabenazine; Vocalization, Animal | 1982 |
[Characterization of the effect of analgesics on the assessment of experimental pain in man. Pethidine and tramadol in a double-blind comparison].
Topics: Adult; Cyclohexanols; Double-Blind Method; Female; Galvanic Skin Response; Humans; Hypnotics and Sedatives; Male; Meperidine; Pain; Sensory Thresholds; Tramadol | 1984 |
[On-demand analgesia with tramadol in bilateral multiple rib fractures].
Topics: Adult; Analgesia; Cyclohexanols; Dyspnea; Female; Humans; Pain; Rib Fractures; Self Administration; Tramadol | 1984 |
A cannabinoid derived prototypical analgesic.
Topics: Analgesics; Animals; Cannabinoids; Cyclohexanols; Dogs; Drug Evaluation, Preclinical; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mice; Models, Molecular; Pain; Rats; Spectrophotometry, Infrared; Structure-Activity Relationship | 1984 |
[Initial experience with the new analgesic Tramal].
Topics: Cyclohexanols; Humans; Pain; Pain, Postoperative; Tramadol | 1984 |
[Double-blind clinical trial of tramadol capsules. First communication: Comparison with pentazocine and placebo (author's transl)].
Topics: Acute Disease; Adult; Aged; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Pain; Pentazocine; Tramadol | 1981 |
[Analgesic effect of tramadol in acute myocardial infarct].
Topics: Cyclohexanols; Humans; Myocardial Infarction; Pain; Tramadol | 1980 |
Venlafaxine for the treatment of chronic pain.
Topics: Adult; Antidepressive Agents, Second-Generation; Back Pain; Chronic Disease; Cyclohexanols; Depressive Disorder; Female; Humans; Pain; Treatment Outcome; Venlafaxine Hydrochloride | 1996 |
Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
Topics: Animals; Body Temperature Regulation; Cannabinoids; Catalepsy; Cyclohexanols; Dronabinol; Male; Maze Learning; Mice; Mice, Inbred ICR; Motor Activity; Nitrogen Mustard Compounds; Pain; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship | 1996 |
Breast pain associated with venlafaxine.
Topics: Adult; Breast; Breast Diseases; Cyclohexanols; Depressive Disorder; Edema; Female; Humans; Male; Pain; Selective Serotonin Reuptake Inhibitors; Sex Factors; Venlafaxine Hydrochloride | 1996 |
Venlafaxine-tramadol similarities.
Topics: Analgesics, Opioid; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Models, Biological; Models, Psychological; Molecular Structure; Pain; Structure-Activity Relationship; Tramadol; Venlafaxine Hydrochloride | 1998 |
Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception.
Topics: Analgesics; Animals; Cannabinoids; Cyclohexanols; Dimethyl Sulfoxide; Dronabinol; Dynorphins; Injections, Spinal; Male; Naltrexone; Narcotic Antagonists; Nociceptors; Pain; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant | 1999 |
Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules.
Topics: Adult; Capsules; Cyclohexanols; Delayed-Action Preparations; Diabetic Neuropathies; Humans; Male; Pain; Venlafaxine Hydrochloride | 1999 |
Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.
Topics: Analgesia; Analgesics; Analgesics, Non-Narcotic; Animals; Arachidonic Acids; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Cannabinoids; Cyclohexanols; Dronabinol; Dynorphins; Endocannabinoids; Endorphins; Male; Pain; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Spinal Cord | 2000 |
Venlafaxine HCl in the treatment of painful peripheral diabetic neuropathy.
Topics: Aged; Aged, 80 and over; Analgesia; Cyclohexanols; Diabetic Neuropathies; Female; Humans; Male; Middle Aged; Pain; Venlafaxine Hydrochloride | 2000 |
Effective treatment of venlafaxine-induced noncyclical mastalgia with bromocriptine.
Topics: Antidepressive Agents, Second-Generation; Breast Diseases; Bromocriptine; Cyclohexanols; Depressive Disorder; Dopamine Agonists; Female; Humans; Middle Aged; Pain; Venlafaxine Hydrochloride | 2000 |
Venlafaxine-induced painful ejaculation.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Ejaculation; Humans; Male; Middle Aged; Pain; Venlafaxine Hydrochloride | 2000 |
Venlafaxine in treatment of severe painful peripheral diabetic neuropathy.
Topics: Adult; Cyclohexanols; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Humans; Pain; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Intrathecal cannabinoid administration suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in rat spinal cord: comparison with morphine.
Topics: Analgesics; Animals; Cannabinoids; Cyclohexanols; Immunosuppressive Agents; Injections, Spinal; Male; Morphine; Nociceptors; Pain; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Spinal Cord | 1999 |
Treatment of neuropathic pain with venlafaxine.
Topics: Adult; Cyclohexanols; Female; Humans; Pain; Peripheral Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
Analgesic effect of tramadol in the rat.
Topics: Analgesics; Animals; Cyclohexanols; Female; Injections, Spinal; Injections, Subcutaneous; Male; Pain; Rats; Rats, Inbred Strains; Sensory Thresholds; Tramadol | 1989 |